SCHEMBL6568019

SCHEMBL6568019

COC(=O)c1cc(NC(=O)Nc2ccccc2Nc2ccccc2)ccc1OC(c1ccccc1)c1ccccc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.51
ALOX15 P16050 1/20 0.51
MEN1 O00255 7/20 0.50
KMT2A Q03164 7/20 0.50
LMNA P02545 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ALDH1A1 P00352 6/20 0.46
GAA P10253 2/20 0.46
RAB9A P51151 5/20 0.45
CASR P41180 1/20 0.44
NPC1 O15118 3/20 0.43
NPSR1 Q6W5P4 3/20 0.43
HTT P42858 1/20 0.43
KDM4E B2RXH2 4/20 0.42
HSD17B10 Q99714 3/20 0.42
HPGD P15428 3/20 0.42
RCE1 Q9Y256 1/20 0.42
POLB P06746 1/20 0.41
HIF1A Q16665 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564786 0.90 KMT2A (0.61) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6566569 0.87 RAB9A (0.51) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6564700 0.87 NPC1 (0.59) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6568068 0.86 LMNA (0.46) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6564782 0.85 LMNA (0.51) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6564504 0.85 KDM4E (0.51) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6566604 0.85 LPAR1 (0.47) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6566290 0.85 MGLL (0.53) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6566734 0.84 MAPT (0.56) MAPTMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6566837 0.84 KMT2A (0.57) MAPTMEN1KMT2ALMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-12-23 US disclosed
EP-1437344-A1 BENZENE DERIVATIVES,PROCESS FOR PREPARING THE SAME AND USE THEREOF Takeda Chemical Industries, Ltd. (JP) 2004-07-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040259912-A1 Benzine derivatives, process for preparing the same and use thereof HRH4, HRH2, HRH1 MAPT 4743/4885ALOX15 2194/4885MEN1 4143/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.